Correlation Between X4 Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on X4 Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for X4 Pharmaceuticals and Blueprint Medicines
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between XFOR and Blueprint is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the Blueprint Medicines. In addition to that, X4 Pharmaceuticals is 4.48 times more volatile than Blueprint Medicines Corp. It trades about -0.07 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.05 per unit of volatility. If you would invest 9,027 in Blueprint Medicines Corp on August 25, 2024 and sell it today you would earn a total of 388.00 from holding Blueprint Medicines Corp or generate 4.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Blueprint Medicines Corp
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Blueprint Medicines Corp |
X4 Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite X4 Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. HCW Biologics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |